Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease
Open Access
- 1 January 2004
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 172 (1), 302-309
- https://doi.org/10.4049/jimmunol.172.1.302
Abstract
The skin is both an essential barrier for host defense and an important organ of immunity. In this study, we show that the application of cholera toxin to intact mouse skin induces and enhances autoimmune diseases affecting organs at distant anatomic sites, whereas its administration by the mucosal route has been reported to have the opposite effect. First, the CNS autoantigen myelin oligodendrocyte glycoprotein 35–55, when applied repeatedly with cholera toxin to the intact skin of healthy C57BL/6 mice, induced relapsing paralysis with demyelinating immunopathologic features similar to multiple sclerosis. Second, the application of cholera toxin in the absence of autoantigen exacerbated the severity of conventional experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein in CFA. Third, the application of cholera toxin to the intact skin of NOD/Lt mice, with or without insulin B peptide 9–23, exacerbated insulitis and T lymphocyte-derived IFN-γ and IL-4 production in the islets of Langerhans, resulting in an increased incidence and rate of onset of autoimmune diabetes. The data presented in this study highlight the different outcomes of adjuvant administration by different routes. Because dermal application of cholera toxin, and other bacterial products with similar adjuvant activities, is being developed as a clinical vaccination strategy, these data raise the possibility that it could precipitate autoimmune disease in genetically susceptible humans.Keywords
This publication has 23 references indexed in Scilit:
- Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA VaccinesJournal of Virology, 2002
- Safety and Immunogenicity of a Prototype EnterotoxigenicEscherichia coliVaccine Administered TranscutaneouslyInfection and Immunity, 2002
- Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-β-secreting cells and suppressing chemokine expressionInternational Immunology, 2000
- Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated AdjuvantsInfection and Immunity, 2000
- DNA immunization to prevent autoimmune diabetesJCI Insight, 1999
- Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor β1 and β2 Chain ExpressionThe Journal of Experimental Medicine, 1999
- Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell cloneInternational Immunology, 1996
- Cholera toxin adjuvant greatly promotes antigen priming of T cellsEuropean Journal of Immunology, 1993
- Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamilyJournal of Neuroscience Research, 1992
- Prevention of type I diabetes in NOD mice by adjuvant immunotherapyDiabetes, 1990